A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

Induced pluripotent stem cells (iPSCs) are pluripotent stem cells generated from adult cells by reprogramming. iPSCs have the same properties as embryonic stem cells, and therefore self-renew and ...

Researchers at Keio University have begun using induced pluripotent stem cells (iPS) to treat and maybe even cure severe spinal cord injuries. The iPS technology was first conceived by Shinya ...

Human induced Pluripotent Stem Cells (hiPSCs), these are cells extracted from a patient's skin or blood and are reprogrammed by researches to replicate as stem cells. Researchers can now examine ...

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

CAMBRIDGE, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...

The treatment begins with "reprogrammed" stem cells, known formally as induced pluripotent stem cells, or iPSCs. These are adult somatic (non-reproductive) cells that have been introduced to ...

Ernexa’s technology transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), which are a specialized type of stem cell that has a unique ability to migrate ...